We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
5E Advanced Materials Boric Acid Validated for LCD Glass Applications
Read MoreHide Full Article
Key Takeaways
FEAM completed a 20-ton commercial tank trial, confirming that boric acid met LCD glass specifications.
FEAM's qualification ran from April lab tests to an August supply-chain trial, ending with a December run.
FEAM cited boron's addition to the 2025 U.S. critical minerals list as context for the milestone.
5E Advanced Materials, Inc. (FEAM - Free Report) said that it has completed a 20-ton commercial tank trial of its boric acid product with a major U.S.-based LCD glass manufacturer, marking a key milestone in its push toward full commercialization. The trial confirmed that 5E’s boric acid met all required specifications, including impurity levels, moisture content, particle size distribution, flowability and overall logistics performance, demonstrating its suitability for use in high-precision LCD glass applications.
This concludes a comprehensive qualification process that started in April 2025 with laboratory testing and advanced through a supply-chain trial completed in August. The successful commercial-scale run, initiated in December 2025, not only validates 5E’s capability to deliver consistent, on-spec product but also moves the company closer to securing an initial offtake agreement with the customer.
The company highlighted that the achievement represents another meaningful milestone on 5E’s path to commercialization, positioning the company with the necessary customer approvals as it works to become a reliable supplier of refined borates and advanced boron materials for fast-growing industrial sectors.
The announcement also follows boron’s recent addition to the U.S. Department of the Interior’s 2025 critical minerals list, underscoring the growing importance of establishing secure domestic supply chains.
Shares of FEAM are up 7.5% over the past six months against the industry’s 4.7% decline.
The Zacks Consensus Estimate for FTK’s current-year earnings is pegged at $1.04 per share, indicating a 206% year-over-year increase. Its earnings beat the Zacks Consensus Estimates in all of the trailing four quarters, with the average earnings surprise of 70%.
The Zacks Consensus Estimate for NVZMY’s current fiscal-year earnings stands at $2.33 per share, reflecting a 24% year-over-year increase. Shares of NVZMY are down by 11.2% over the past six months.
The Zacks Consensus Estimate for CMC’s current fiscal-year earnings is pegged at $7.12 per share, indicating a 127.5% year-over-year increase. Shares of CMC are up by 35% over the past six months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
5E Advanced Materials Boric Acid Validated for LCD Glass Applications
Key Takeaways
5E Advanced Materials, Inc. (FEAM - Free Report) said that it has completed a 20-ton commercial tank trial of its boric acid product with a major U.S.-based LCD glass manufacturer, marking a key milestone in its push toward full commercialization. The trial confirmed that 5E’s boric acid met all required specifications, including impurity levels, moisture content, particle size distribution, flowability and overall logistics performance, demonstrating its suitability for use in high-precision LCD glass applications.
This concludes a comprehensive qualification process that started in April 2025 with laboratory testing and advanced through a supply-chain trial completed in August. The successful commercial-scale run, initiated in December 2025, not only validates 5E’s capability to deliver consistent, on-spec product but also moves the company closer to securing an initial offtake agreement with the customer.
The company highlighted that the achievement represents another meaningful milestone on 5E’s path to commercialization, positioning the company with the necessary customer approvals as it works to become a reliable supplier of refined borates and advanced boron materials for fast-growing industrial sectors.
The announcement also follows boron’s recent addition to the U.S. Department of the Interior’s 2025 critical minerals list, underscoring the growing importance of establishing secure domestic supply chains.
Shares of FEAM are up 7.5% over the past six months against the industry’s 4.7% decline.
Image Source: Zacks Investment Research
FEAM’s Zacks Rank & Key Picks
FEAM currently carries a Zacks Rank of #4 (Sell).
Better-ranked stocks in the Basic Materials space include Flotek Industries, Inc. (FTK - Free Report) , Novozymes A/S (NVZMY - Free Report) and Commercial Metals Company (CMC - Free Report) . FTK and CMC sport a Zacks Rank of #1 (Strong Buy), while NVZMY carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for FTK’s current-year earnings is pegged at $1.04 per share, indicating a 206% year-over-year increase. Its earnings beat the Zacks Consensus Estimates in all of the trailing four quarters, with the average earnings surprise of 70%.
The Zacks Consensus Estimate for NVZMY’s current fiscal-year earnings stands at $2.33 per share, reflecting a 24% year-over-year increase. Shares of NVZMY are down by 11.2% over the past six months.
The Zacks Consensus Estimate for CMC’s current fiscal-year earnings is pegged at $7.12 per share, indicating a 127.5% year-over-year increase. Shares of CMC are up by 35% over the past six months.